What a difference a vaccine makes

The announcement that a vaccine might be available before the end of the month that works and is safe changed everything – and nothing.

This content is more than 6 months old now, please visit the news area of this site for more recent content

  1. Charles Stanley

The optimists in markets decided that the news would be confirmed and get better. They think the vaccine they will complete its trials, it will pass its safety test – and the regulators will wave it through into use many months short of the normal trial periods. It would, they hope, be followed by one or two more vaccines that could similarly be fast tracked, as if one company can find a way to stop the disease so surely must others be able to do the same.

If you think forward to a time when most people who want to be are inoculated, and when Covid-19 has gone away – or is well under control for want of more people to infect – you can sketch a return to normal in a wide range of areas. People will fly on holiday again, tourism and hospitality will flourish, and maybe more business will be done face-to-face after all.

Shares and sectors which have been badly damaged by the current absence of customers, the shortage of turnover and the outright bans on opening should bounce substantially as investors see they will return to better turnover, cashflow and profitability after the crowds return to use them. This is why the shares of wounded companies bounced so much.

In the shorter term, however, nothing has changed. We await the successful completion of trials – and await the difficult decision of the regulators as to whether there has been sufficient proof of the safety and efficacy of this product. All may go well on these fronts, as there is huge establishment pressure for this to work. There remain substantial manufacturing and logistics issues with producing and delivering this vaccine to enough people to allow full relaxation of social-distancing and business controls.

Logistical issues

The vaccine needs to be kept at much lower temperatures than normal surgery fridges and will require special transport and storage. The whole world wants this vaccine so each individual country will be rationed. In the first instance, the vaccine will probably be used for the most vulnerable and for health workers – and will not be available for the majority. This will make governments cautious about sounding the all-clear and will leave us still fighting the virus for the months ahead through the current chosen methods of reducing social contacts and enforcing various lockdowns. The addition of other vaccines on the approved list would help speed the transition.

Nor is it guaranteed that we will pass effortlessly and easily back to the old normal in many areas. Online shopping will keep some of its accelerated gains, and High Street chains weakened by periods of closure for the pandemic will cut stores or go out of business more rapidly. There will be some return to the office, but more homeworking is likely to become entrenched now people have worked out how to do it and see that it brings them welcome flexibilities.

The Green revolution will remain a serial disrupter of all the carbon-based businesses from oil and gas production through conventional cars to filling stations and the domestic boiler business, especially if, as the markets expect, Joe Biden does become the official President-elect. The response to Covid-19 speeded up changes and trends that were underway before February 2020. The passing of Covid-19, if that is what happens, will not change many of those trends. We have yet to see just how much debt the worst affected companies have taken on to get through long lockdowns with little or no revenue. Whilst governments can borrow at around zero higher risk companies have no such luxury. There will be more capital reconstructions, refinancings and bankruptcies before this disease is played out.

2021 optimism

It looks as if the new establishment in the US and the Europeans are keen to see a vaccine or two up and running. It is likely that as we enter the spring in the northern hemisphere next year the virus will be on the wane again allowing a more relaxed policy stance. This is worth some progress by shares in sectors that will recover when the pall of the virus is removed.

It also means less special growth rates for the lockdown winners in technology that provided the online alternative. It does not, however, mean an end to the digital or green revolutions, and does not guarantee the survival of all those hospitality, travel, tourism and leisure businesses that have been damaged by events so far.

A bit more balance in equity portfolios makes sense, but buying up all the problem companies will still leave you with plenty to worry about in the portfolio as we work through the slow progress of vaccine adoption, and the long tail of inherited damage from the disruptions so far.

Nothing on this website should be construed as personal advice based on your circumstances. No news or research item is a personal recommendation to deal.

More from author

  1. Charles Stanley

    Running hot – but not too hot?

    Date: 5th Mar 2021 12:37pm

    The leading central banks and governments remain of the view that inflation will not ...

  2. Charles Stanley

    Examining good and bad inflation

    Date: 3rd Mar 2021 14:25pm

    For once, central banks might be right about price rises. Inflation may not rise so r...

  3. Charles Stanley

    India looks forward to a better year

    Date: 1st Mar 2021 12:47pm

    India has experienced a less widespread attack of Covid-19 than the advanced countrie...

Most read articles

  1. What a difference a vaccine makes

    Running hot – but not too hot?

    Date: 5th Mar 2021 12:37pm

    The leading central banks and governments remain of the view that inflation will not ...

  2. What a difference a vaccine makes

    Budget 2021 – the impact on personal finances and investments

    Date: 3rd Mar 2021 14:32pm

    Rob Morgan rounds up the main developments from today’s Budget and next tax year’s ke...

  3. What a difference a vaccine makes

    Examining good and bad inflation

    Date: 3rd Mar 2021 14:25pm

    For once, central banks might be right about price rises. Inflation may not rise so r...

Investment involves risk. You may get back less than invested.